Oncimmune Holdings PLC (AIM:ONC) - Administration

Oncimmune Holdings PLC (AIM:ONC), a UK-headquartered immunology company specialising in precision medicine, entered administration on 26 March.

Despite a comprehensive sale process and positive interest in the business, the company was unable to secure a buyer for its German trading subsidiary, or to raise the additional capital required to meet its short term funding needs.

Simon Bonney and James Varney of Arafino Advisory were appointed joint administrators.

White & Case and Pinsent Masons are advising the company.

Various IPF Partners have registered charges against the company.